Novel Amanitin-Based Antibody–Drug Conjugates Targeting TROP2 for the Treatment of Pancreatic Cancer
Eleni Papacharisi(Heidelberg Pharma (Germany)), Torsten Hechler(Heidelberg Pharma (Germany))
Cited by 11
Related Papers
Amanitin-Based Fc-Small Molecule–Drug Conjugates with Noncleavable Linker: A Novel Therapeutic Strategy for Prostate Cancer Targeted Therapy
|Molecular Cancer Therapeutics|2026|0